Syntax Research’s Medtronic MDT Stock Holding History

Syntax Research’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.9K	Sell	803 -5,637	-88%	-$455K	0.05%	88
2026 Q1	$558K	Sell	6,440 -539	-8%	-$51.6K	0.36%	49
2025 Q4	$670K	Buy	6,979 +151	+2%	+$14.7K	0.41%	47
2025 Q3	$650K	Buy	6,828 +305	+5%	+$28K	0.42%	49
2025 Q2	$569K	Buy	6,523 +646	+11%	+$54.8K	0.4%	44
2025 Q1	$528K	Buy	5,877 +49	+0.8%	+$4.38K	0.36%	48
2024 Q4	$466K	Sell	5,828 -491	-8%	-$42.5K	0.33%	46
2024 Q3	$569K	Buy	6,319 +5,408	+594%	+$455K	0.38%	43
2024 Q2	$71.7K	Sell	911 -5,122	-85%	-$420K	0.06%	71
2024 Q1	$526K	Buy	6,033 +219	+4%	+$18.7K	0.4%	40
2023 Q4	$479K	Buy	5,814 +228	+4%	+$17.4K	0.4%	40
2023 Q3	$438K	Buy	+5,586	New	+$468K	0.35%	44

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Syntax Research's MDT Position: Q2 2026 in Review

Syntax Research reduced its Medtronic (MDT) stake by 88% in Q2 2026, selling an estimated $455K and leaving 803 shares worth $62.9K. The position accounts for 0.05% of the portfolio, ranked #88.

Syntax Research first reported a position in MDT in Q3 2023 and has held it in 12 quarters since. The position peaked at $670K in Q4 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Syntax Research held 803 shares of Medtronic worth $62.9K as of Q2 2026.
Syntax Research sold 5,637 Medtronic shares in Q2 2026, an estimated $455K.
Medtronic made up 0.05% of Syntax Research's portfolio in Q2 2026, its #88 holding.
Syntax Research first reported a position in Medtronic in Q3 2023 and has held it in 12 quarters since.
Syntax Research's Medtronic position peaked at $670K in Q4 2025.
2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.